DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
ASND
ASCENDIS PHARMA A/S
260 institutions still hold ASCENDIS PHARMA A/S as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 04351P101·Pharmaceutical Preparations·260 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
260 institutions reported ASND in Q1 2026. RA CAPITAL MANAGEMENT, L.P. leads at 23.3% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 13
240 more holders available. Log in →